Actavis, Inc. - FORM 8-K - EX-99.2 - EXHIBIT 99.2 - February 15, 2011

Attached files

file	filename
8-K - FORM 8-K - Actavis, Inc.	c12587e8vk.htm
EX-99.3 - EXHIBIT 99.3 - Actavis, Inc.	c12587exv99w3.htm
EX-99.1 - EXHIBIT 99.1 - Actavis, Inc.	c12587exv99w1.htm
EX-99.4 - EXHIBIT 99.4 - Actavis, Inc.	c12587exv99w4.htm

Exhibit 99.2

STATEMENT OF OPERATIONS GAAP TO NON-GAAP ADJUSTMENTS BY LINE ITEM
October 1, 2010 — December 31, 2010


		Generic Segment																				Brand Segment																												*(Gain)*
																		*Total Generic*																				*Total Brand*												*loss on*																				*Total After-*
		*Other*								*Sales and*								*Segment*				*Other*								*Sales and*								*Segment*												*sale of*				*Interest*				*Other*				*Total Pre-tax*								*tax*
*Expense Type*		*Revenue*				*COS*				*Marketing*				*R&D*				*Adjustments*				*Revenue*				*COS*				*Marketing*				*R&D*				*Adjustments*				*G&A*				*Amortization*				*assets*				*Expense*				*income*				*Adjustments*				*Tax Effect*				*Adjustments*
Amortization		$	—			$	—			$	—			$	—			$	—			$	—			$	—			$	—			$	—			$	—			$	—			$	52.0			$	—			$	—			$	—			$	52.0			$	(15.4	)		$	36.6
Acquisition and licensing charges			(25.0	)			—				—				—				(25.0	)			—				—				—				24.9				24.9				4.9				—				—				8.2	⁽¹⁾			—				13.0				(7.9	)			5.1
Global supply chain initiative			—				8.5				—				2.9				11.4				—				—				—				—				—				0.4				—				—				—				—				11.8				(3.8	)			8.0
Legal settlements			—				—				—				—				—				—				—				—				—				—				40.0				—				—				—				—				40.0				(14.0	)			26.0
Asset sales/impairments			—				—				—				—				—				—				—				—				—				—				—				—				29.6				—				1.8				31.4				(9.2	)			22.2
(Gain) loss on securities			—				—				—				—				—				—				—				—				—				—				—				—				—				—				(0.8	)			(0.8	)			0.3				(0.5	)
Loss on early extinguishment of debt			—				—				—				—				—				—				—				—				—				—				—				—				—				—				0.5				0.5				(0.2	)			0.3

Totals by Segment and P&L Line Item		$	(25.0	)		$	8.5			$	—			$	2.9			$	(13.6	)		$	—			$	—			$	—			$	24.9			$	24.9			$	45.3			$	52.0			$	29.6			$	8.2			$	1.5			$	147.9			$	(50.2	)		$	97.7

Other tax items																																																																			0.5				0.5


																														*(Gain)*
																		*Total*												*loss on*
		*Other*								*Sales and*								*Segment*												*sale of*				*Interest*				*Other*				*Total Pre-tax*
		*Revenue*				*COS*				*Marketing*				*R&D*				*Adjustments*				*G&A*				*Amortization*				*assets*				*Expense*				*Income*				*Adjustments*

Totals by P&L Line Item		$	(25.0	)		$	8.5			$	—			$	27.8			$	11.3			$	45.3			$	52.0			$	29.6			$	8.2			$	1.5			$	147.9			$	(49.7	)		$	98.2


(1) Included within acquisition and licensing charges are interest accretion charges on the following obligations:

Atorvastatin contingent consideration obligation																																		$	3.1
Manditorily Redeemable Preferred Stock																																			3.9
Columbia contingent consideration obligation																																			1.2

																																		$	8.2